NewGenIvf Group Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for NewGenIvf Group Limited (NIVF) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021
Period EndingDec 2024Dec 2023Dec 2022Dec 2021
Operating Activities
Net Income-0.520.130.460.00
Depreciation & Amortization0.210.230.300.34
Deferred Income Tax-0.490.000.210.00
Stock Based Compensation0.030.000.000.00
Change in Working Capital-7.77-2.090.710.73
Change in Accounts Receivable-0.040.000.130.06
Change in Inventory0.05-0.08-0.010.00
Change in Accounts Payable1.130.070.06-0.06
Change in Other Working Capital1.20-0.730.240.20
Other Operating Activities1.20-0.040.240.20
Net Cash from Operating Activities-8.26-1.771.711.43
Investing Activities
Capital Expenditures-0.05-0.07-0.09-0.02
Net Cash from Investing Activities-0.05-0.07-0.09-0.02
Financing Activities
Debt Repayment-0.01-0.01-0.02-0.02
Common Stock Issued0.130.190.000.00
Other Financing Activities0.78-0.16-1.74-2.04
Net Cash from Financing Activities8.681.88-1.63-1.54
Summary
Effect of Forex Changes on Cash0.04-0.020.020.05
Net Change in Cash0.360.03-0.02-0.13
Cash at Beginning of Period0.050.030.030.11
Cash at End of Period0.460.050.030.03
Free Cash Flow-8.32-1.841.621.42
Supplemental Disclosures
Interest Paid0.770.020.060.07
Income Taxes Paid0.000.000.010.00